Cerenome
$3.87
231
+$0.22+6.03% Friday 20:00
+$0.00+0%Friday 23:37After hours
Statistics
Day High
3.94
Day Low
3.62
52W High
23.43
52W Low
2.9
Volume
96,526
Avg. Volume
159,311
Mkt Cap
29.37M
P/E Ratio
0.19
Dividend Yield
-
Dividend
-
Upcoming
Earnings
15OctExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-1.19
-0.79
-0.38
0.02
Expected EPS
-0.885
Actual EPS
N/A
Financials
-429.43%Profit Margin
Unprofitable5.21MRevenue
-22.39MNet Income
Analyst Ratings
57.00Average Price Target
The highest estimate is 57.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PSTV. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Mustang Bio
MBIO
Mkt Cap4.07M
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
Fate Therapeutics
FATE
Mkt Cap291.16M
Allogene Therapeutics
ALLO
Mkt Cap697.89M
About
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Show more...
CEO
Marc H. Hedrick
Employees
28
Country
United States
ISIN
US72941H8060
WKN
000A422GY
Listings
0 Comments
Share your thoughts
FAQ
What is Cerenome stock price today?▼
The current price of PSTV is $3.87 USD — it has increased by +6.03% in the past 24 hours. Watch Cerenome stock price performance more closely on the chart.
What is Cerenome stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Cerenome stocks are traded under the ticker PSTV.
Is Cerenome stock price growing?▼
PSTV stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Cerenome has showed a -68.5% decrease.
What is Cerenome market cap?▼
Today Cerenome has the market capitalization of 29.37M
When is the next Cerenome earnings date?▼
Cerenome is going to release the next earnings report on October 15, 2026.
What were Cerenome earnings last quarter?▼
PSTV earnings for the last quarter are -1.05 USD per share, whereas the estimation was -0.85 USD resulting in a -23.82% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cerenome revenue for the last year?▼
Cerenome revenue for the last year amounts to 5.21M USD.
What is Cerenome net income for the last year?▼
PSTV net income for the last year is -22.39M USD.
How many employees does Cerenome have?▼
As of September 06, 2026, the company has 28 employees.
In which sector is Cerenome located?▼
Cerenome operates in the Health & Wellness sector.
When did Cerenome complete a stock split?▼
The last stock split for Cerenome was on April 02, 2026 with a ratio of 1:25.
Where is Cerenome headquartered?▼
Cerenome is headquartered in HOUSTON, United States.